Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

• Main Authors: Noriko Kudo (Author), Hidenaga Yamamori (Author), Tamaki Ishima (Author), Kiyotaka Nemoto (Author), Yuka Yasuda (Author), Michiko Fujimoto (Author), Hirotsugu Azechi (Author), Tomihisa Niitsu (Author), Shusuke Numata (Author), Manabu Ikeda (Author), Masaomi Iyo (Author), Tetsuro Ohmori (Author), Masaki Fukunaga (Author), Yoshiyuki Watanabe (Author), Kenji Hashimoto (Author), Ryota Hashimoto (Author)
• Format: Book
• Published: Wiley, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Aim Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the pos...